ALLMedicine™ Gallstones Center

Feb 28th, 2023 - Routine urgent endoscopic retrograde cholangiopancreatography (ERCP) with endoscopic biliary sphincterotomy (ES) does not improve outcome in patients with predicted severe acute biliary pancreatitis. Improved patient selection for ERCP by means of...

Feb 28th, 2023 - Gallstones are a very common problem in developed countries. Most patients with gallstones remain asymptomatic throughout their lifetime, but 10 % - 25 % of them may develop biliary pain or complications, with an annual risk of about 2 % - 3 % for...

Feb 22nd, 2023 - Obesity has been a health problem of growing significance all over the world; its prevalence is increasing in both developed and developing countries . According to WHO data, 39% of the global population above 18 years of age are overweight and of...

Feb 17th, 2023 - This study aims to evaluate the relation between the cystocholedochal angle (SCA) and choledocholithiasis. The data of 3.350 patients were reviewed retrospectively and a total of 628 patients who met the criteria were included in the study. The pa...

Feb 15th, 2023 - Detection of gallbladder gallstone using Dual Energy CT compare to gallblader ultrasound (gold standard). All patients who undergo dual-energy CT scans will undergo abdominal ultrasound for gallstones. Performance of CT to conventionnal KeV will b...

Oct 17th, 2018 - More than 35% of men and 40% of women in the United States are obese. Obesity is associated with health problems such as increased risk for coronary heart disease, type 2 diabetes, various types of cancer, gallstones, and disability. Obesity is al...

Feb 28th, 2023 - Gallstones are a very common problem in developed countries. Most patients with gallstones remain asymptomatic throughout their lifetime, but 10 % - 25 % of them may develop biliary pain or complications, with an annual risk of about 2 % - 3 % for...

Feb 22nd, 2023 - Obesity has been a health problem of growing significance all over the world; its prevalence is increasing in both developed and developing countries . According to WHO data, 39% of the global population above 18 years of age are overweight and of...

Feb 15th, 2023 - Detection of gallbladder gallstone using Dual Energy CT compare to gallblader ultrasound (gold standard). All patients who undergo dual-energy CT scans will undergo abdominal ultrasound for gallstones. Performance of CT to conventionnal KeV will b...

Feb 15th, 2023 - Laparoscopic cholecystectomy has been accepted and is nowadays considered as the gold standard treatment of gallstones disease. Conventional laparoscopic cholecystectomy (CLC) was defined as three or four port surgery carried out with either Frenc...

Feb 10th, 2023 - The prevalence of gallstones is 10% and approximately 10% of patients develop acute cholecystitis (AC). AC prevalence increases with age and complications are as high as 30% in patients who do not undergo surgery, the only definitive treatment. Th...

Dec 29th, 2022 - The FDA approved injectable semaglutide 2.4 mg (Wegovy) for people with obesity ages 12 and up, maker Novo Nordisk announced. When paired with diet and exercise, it's now indicated for use in adolescents with an initial BMI at or above the 95th pe...

Nov 8th, 2022 - Individuals from every region of the world are affected by overweight and obesity. Globally, the prevalence of obesity has increased dramatically in the past 50 years, making it a significant public health crisis that is associated with increased ...

Sep 4th, 2022 - Percutaneous transhepatic gallbladder drainage (PT-GBD) is the most common, nonoperative method for gallbladder decompression in patients unfit for cholecystectomy. However, drain-related complications (20%-75%), including tube changes, dyscosmesi.

Jun 15th, 2022 - NEW YORK (Reuters Health) - Employment of an augmented reality-assisted navigation system (AR-ANS) during hepatectomy for hepatolithiasisiIncreases operative time but reduces the risk of residual and recurrent stones, a retrospective study suggest...

Apr 14th, 2022 - Treatment with mitapivat (Pyrukynd) increased hemoglobin levels and decreased hemolysis in patients with pyruvate kinase (PK) deficiency who did not require regular blood transfusions, the randomized ACTIVATE trial showed. For the phase III study'...